Photo of Mike Quigley
D United States House · District 5 · Illinois On the 2026 ballot

Rep. Mike Quigley

Compare
Total votes
2,837
all sessions
Attendance
97%
90 missed
Near the chamber average
With party
98%
of cast votes
Near the chamber average
Bipartisan score
1%
crosses aisle rarely
Near the chamber average
Sponsored
1,559
bills & resolutions
Higher than 86% of chamber peers
Committees
7
assignments
1,559 bills and resolutions

Sponsored bills

Total
1,559
Primary
50
Co-sponsor
1,509
This page
1,559
matching current filters
Co-sponsor HR 1262
Passed · United States House · Co-sponsor
Mikaela Naylon Give Kids a Chance Act

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Passed Dec 2, 2025 1 co-sponsor
Co-sponsor HRES 915
In committee · United States House · Co-sponsor
Expressing the sense of the House of Representatives that the Ukrainian famine of 1932-1933, known as the Holodomor, is recognized as a genocide and should serve as a reminder of repressive Soviet policies against the people of Ukraine.

Maddy summaryHRES 915 formally recognizes the 1932-1933 Ukrainian famine, known as the Holodomor, as a genocide perpetrated by the Soviet Union. The resolution directly affects Ukrainian victims, survivors, and communities by affirming historical truth and condemning Soviet policies that intentionally starved millions. Key provisions include declaring the Holodomor a genocide, commemorating its victims, and condemning ongoing Russian aggression against Ukraine, including Vladimir Putin’s denial of Ukrainian sovereignty. This symbolic resolution aims to educate the public and align U.S. policy with historical facts about Soviet repression.

In committee Nov 28, 2025 1 co-sponsor
Co-sponsor HR 6280
In committee · United States House · Co-sponsor
Access to Genetic Counselor Services Act of 2025

Maddy summaryThis bill expands Medicare coverage to include genetic counseling services provided by licensed or certified genetic counselors, effective January 1, 2027. It defines "covered genetic counseling services" as those furnished by qualified counselors under state law or certification, with payments set at 80% of the lesser of the actual charge or 85% of the physician fee schedule. Medicare beneficiaries seeking genetic counseling will gain access to these services through covered providers, while preventing balance billing for these specific services. The bill does not restrict physicians from billing for similar services under existing Medicare rules.

In committee Nov 21, 2025 1 co-sponsor
Co-sponsor HRES 899
In committee · United States House · Co-sponsor
Supporting the goals and principles of Transgender Day of Remembrance by recognizing the epidemic of violence toward transgender people and memorializing the lives lost this year.

Maddy summaryHRES 899 is a symbolic House resolution recognizing the Transgender Day of Remembrance and memorializing transgender people killed by violence in 2024-2025. It directly affects transgender individuals, particularly transgender women of color, by acknowledging the epidemic of violence against them - citing 27 U.S. victims (including names like Rick Alastor Newman and Kyla Jane Walker) and 241 global cases in 2025. The resolution’s key provisions include formally recognizing the violence epidemic, memorializing specific lives lost, and affirming the need for solutions to protect transgender people. It does not create new laws but expresses congressional support for addressing systemic violence and discrimination faced by transgender communities.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6215
In committee · United States House · Co-sponsor
Small Business RELIEF Act

Maddy summaryHR 6215, the Small Business RELIEF Act, exempts small businesses from import duties imposed under Executive Order 14257 (90 Fed. Reg. 15041) for goods they import or use. It requires the President to refund duties paid by small businesses within 90 days of the bill's enactment. The bill defines "small business concern" using the standard Small Business Act criteria (15 U.S.C. 632). This directly affects small businesses importing goods, providing immediate cost relief by removing a specific tariff and refunding past payments.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6170
In committee · United States House · Co-sponsor
ADOPT Act of 2025

Maddy summaryThe ADOPT Act of 2025 creates federal offenses to prevent exploitation in private domestic interstate adoptions. It prohibits unlicensed groups from acting as intermediaries between birth parents and adoptive parents, restricts certain adoption advertising, and caps payments to birth parents at $2,500 before consulting a licensed agency or attorney. The bill directly affects unlicensed adoption facilitators, birth parents, and prospective adoptive parents by requiring all adoption services to occur through licensed providers or exempt entities like attorneys and nonprofit agencies. Violations carry fines up to $100,000 for organizations or $50,000 plus 5 years in prison for individuals, with exemptions for public agencies, licensed child-placing organizations, and attorneys.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6176
In committee · United States House · Co-sponsor
Electricity Transmission Scorecard Act

Maddy summaryThe Electricity Transmission Scorecard Act (HR 6176) requires electricity transmission owners and regional grid operators to publicly report on their performance using standardized metrics. It mandates biannual reports from transmission owners (TIAPS) and annual reports from regional grid operators (RIAPS) covering affordability, investment effectiveness, system reliability, interconnection fairness, and other key performance indicators. The bill establishes a framework for transparent, comparable data that would be publicly accessible through a government portal, allowing ratepayers and stakeholders to evaluate transmission service quality. This applies to all entities operating transmission facilities, including those not previously subject to FERC reporting requirements, aiming to improve transparency and accountability in electricity transmission.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6179
In committee · United States House · Co-sponsor
Clean Cloud Act of 2025

Clean Cloud Act of 2025 This bill establishes an emissions standard and fee system regarding the electricity used by data centers or cryptomining facilities that exceed a specified size. Additionally, the bill appropriates collected fees for various purposes, including to fund zero-carbon electricity generation, long-duration energy storage, and grants to lower residential electricity consumer costs. The bill requires the Environmental Protection Agency (EPA) and the Energy Information Administration to annually determine the greenhouse gas emission intensity of the total annual electricity consumed by (1) covered facilities from the electric grid, and (2) covered facilities from electricity generation assets located behind the power meter of the facilities. The EPA must determine and publish the greenhouse gas emissions intensities of the electric grid of each region to establish a baseline for the assessment of fees. Each calendar year from 2027 through 2034, the baseline for each region is reduced by 11% of the original baseline. For 2035 and after, the baseline is set to zero emissions. The EPA must assess a fee on (1) owners of any electric utility providing power to a covered facility that exceeds the baseline emissions in that region for that year, and (2) covered facilities with respect to the greenhouse gas emissions from electricity generation assets located behind the power meter of the facility above the baseline of the region for that year. The electric utilities may not recoup the cost of the fee by raising rates or assessing fees on customers that are not covered facilities.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6166
In committee · United States House · Co-sponsor
Lowering Drug Costs for American Families Act

Maddy summaryThis bill expands Medicare's drug price negotiation program to cover 50 drugs (up from 20) and requires health insurers to apply negotiated prices to cost-sharing for beneficiaries. It establishes annual out-of-pocket cost-sharing limits for prescription drugs under group health plans and insurance coverage, with specific limits of $2,000 for self-only coverage in 2027 that will increase annually. The bill also sets specific cost-sharing limits for insulin products, requiring coverage with no deductible and cost-sharing of no more than $35 per 30-day supply or 25% of the negotiated price. These provisions affect Medicare beneficiaries, people with group health plans, and health insurers across the country. The bill applies to plan years beginning on or after January 1, 2027.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6177
In committee · United States House · Co-sponsor
Grid Research and Development Act

Maddy summaryThe Grid Research and Development Act (HR 6177) requires transmission utilities and grid operators to report standardized data to the Federal Energy Regulatory Commission (FERC) on transmission projects, including costs, project timelines, system performance, and interconnection expenses. FERC must create a public, searchable data repository and an Interconnection Data Dashboard displaying real-time queue data, project statuses, and system costs to improve transparency. The Department of Energy will use this data to research transmission cost drivers, efficiency, and affordability, publishing annual reports on grid investment impacts. These requirements directly affect transmission utilities, grid operators, and ratepayers by standardizing reporting and enabling public analysis of grid investments.

In committee Nov 20, 2025 1 co-sponsor
Showing 231 to 240 of 1,559 bills
Previous 1 … 23 24 25 … 156 Next